Personalizing cancer treatment using genetic test results
Official title: Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
Funded at Stanford University · NIH-11049165 · Data updated 2026-11-12
This study is looking at how genetic testing can help personalize cancer treatment and prevention for patients with different types of cancer, like breast and prostate cancer, so they can better understand their options based on their unique genetic information.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | March 5, 2024 |
| Project end | February 28, 2029 |
| Funding year | 2025 |
| Award (this year) | $654,143 |
| NIH project number | 5R01CA283207-02 |
| Project ID | NIH-11049165 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with breast, ovarian, pancreatic, or advanced prostate cancer who have undergone genetic testing.
✕Less likely to help
Patients with cancer types not covered by the genetic testing guidelines or those who have not undergone genetic testing may not benefit from this research.
What this research studies
This research investigates how genetic testing results can be effectively integrated into cancer treatment and prevention strategies for patients. It focuses on patients diagnosed with various types of cancer, including breast, ovarian, pancreatic, and advanced prostate cancer, and aims to personalize their treatment based on genetic information. By linking genetic testing data with cancer registry records, the study seeks to understand current practices and improve the management of genetic test results across different cancer types. Patients may be involved in discussions about their genetic test results and how these can influence their treatment options.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual genetic profiles.
How similar studies have gone: Previous research has shown promising results in integrating genetic testing into cancer treatment, indicating that this approach could be beneficial.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Kurian, Allison W. — Stanford University
- Study coordinator: Kurian, Allison W.
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.